Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v8-EN
Language English English
Date Updated 2020-01-21 2020-01-20
Drug Identification Number 02305933 02305933
Brand name STALEVO STALEVO
Common or Proper name STALEVO FCT 50MG 100'S STALEVO FCT 50MG 100'S
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients ENTACAPONE CARBIDOPA LEVODOPA ENTACAPONE CARBIDOPA LEVODOPA
Strength(s) 200MG 12.5MG 50MG 200MG 12.5MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100'S 100'S
ATC code N04BA N04BA
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-12-19 2019-12-19
Actual start date 2019-12-19 2019-12-19
Estimated end date 2020-01-15 2020-01-15
Actual end date 2020-01-20 2020-01-20
Shortage status Resolved Actual shortage
Company comments Supply interruption Supply interruption
Health Canada comments